Orlando, FL - 2013 Genitourinary Cancers Symposium - Orlando, FL: Duncan C. Gilbert MD discusses Abstract #319 - Prediction of relapse in stage I nonseminomatous germ cell tumors (NSGCT) by CXCL12: Results from the MRC TE08 and TE22 clinical trials. during the Oral Abstract Session B: Urothelial Carcinoma and Testicular Cancer at the Genitourinary Cancers Symposium 2013 here today, Friday February 15, 2013. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, the American Society of Radiation Oncology and SUO, the Society of Urologic Oncology. Over 2,500 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Rosen Shingle Creek in Orlando and features the latest Genitourinary Cancers research in the areas of basic and clinical science. Date: Friday February 15, 2013. Photo by © ASCO/Todd Buchanan 2013 Technical Questions: firstname.lastname@example.org; Phone: 612-226-5154.